IntelliGenome, an innovative molecular diagnostic solutions provider, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its ...
AArly DETECT 2 feasibility study designed to validate earlier results on advanced adenomas over a large population of average risk patients. Multi-center study expected to comple ...
On January 14, a 25-year-old Quarter Horse mare in Tuscola County, Michigan, tested positive for strangles after developing nasal discharge and swollen lymph nodes. Two additional horses on the ...